Larry L. Froelich

Phosphatidylinositol 3-kinase activation is required for insulin-stimulated sodium transport in A6 cells

Rae Record, Larry L. Froelich, Chris J. Vlahos et al. · American Journal of Physiology-Endocrinology and Metabolism · 1998 · 92 citations

Cellular Physiology, Pp70 S6 Kinase, Insulin Signaling +21

Design, synthesis, and pharmacological evaluation of potent xanthone dicarboxylic acid leukotriene B4 receptor antagonists

William T. Jackson, Robert J. Boyd, Larry L. Froelich et al. · Journal of Medicinal Chemistry · 1993 · 64 citations · Full text

Medicinal Chemistry, Biochemistry, Functional Selectivity +14

Pharmacologic Actions of the Second-Generation Leukotriene B4 Receptor Antagonist LY293111: In Vitro Studies

William T. Jackson, Larry L. Froelich, Robert J. Boyd et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 58 citations

Blockade of human neutrophil activation by 2-[2-propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]propoxy]phenoxy]benzoic acid (LY293111), a novel leukotriene B4 receptor antagonist

Philip Marder, J. Scott Sawyer, Larry L. Froelich et al. · Biochemical Pharmacology · 1995 · 52 citations

Inflammation, Anti-inflammatory, Benzoic Acid +8

Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones

David K. Herron, Theodore Goodson, Nancy G. Bollinger et al. · Journal of Medicinal Chemistry · 1992 · 51 citations

Molecular Pharmacology, Medicinal Chemistry, Human Pmn +13